Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Electroporation Potentiated Immunotherapy in Liver Metastatic

NCT04835402 is registered in ClinicalTrials.gov with Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery as lead sponsor.

NCT NCT04835402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04835402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Electroporation Potentiated Immunotherapy in Liver Metastatic
Lead sponsor
Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery
Phase
Phase 2
Overall status
Unknown status
Start date
May 26, 2021
Completion date
December 31, 2025
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas cancer, metastatic